Trial Profile

Immunogenicity Assessment of Pentacel (Hybrid CP20/20/5/3DT-mIPV//PRP-T) When Given at Different Times From or Concurrently With a Pneumococcal Conjugate Vaccine.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 03 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
Indications Diphtheria; Haemophilus infections; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
Focus Adverse reactions; Pharmacodynamics
Sponsors Sanofi

Most Recent Events

03 Jul 2010 Primary endpoint 'Immunological response' has been met.
03 Jul 2010 Results reported in Vaccine.
14 Nov 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com